Medicare Enrolled
Dr. Manreet Basra, M.D.
Cardiovascular Disease · Stockton, CA
Practice pattern: Cardiac & Electrophysiology
— Practice combining cardiac and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Basra from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Basra?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Basra
Dr. Manreet Basra is a cardiovascular disease specialist in Stockton, CA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Basra performed 3,136 Medicare services across 2,248 unique beneficiaries.
Between the years covered by Open Payments, Dr. Basra received a total of $6,970 from 39 pharmaceutical and/or device companies across 285 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Basra is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 35% volume in CA
$6,970 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,136
Medicare services
Top 35% in CA for cardiovascular disease
2,248
Unique beneficiaries
$79
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~196 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
816 | $93 | $280 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
585 | $11 | $46 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
233 | $151 | $581 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
208 | $44 | $120 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
144 | $76 | $187 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
128 | $157 | $463 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
90 | $168 | $469 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
88 | $95 | $211 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
87 | $127 | $360 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
86 | $9 | $30 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
81 | $52 | $211 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
72 | $368 | $1,224 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
58 | $17 | $80 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
49 | $21 | $86 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
46 | $85 | $280 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
46 | $2 | $10 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
45 | $14 | $47 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
44 | $57 | $221 |
| Routine 12-lead electrocardiogram (ECG) A test that records the electrical activity of the heart using at least 12 leads to produce a tracing. |
33 | $5 | $46 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
32 | $55 | $301 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
29 | $6 | $21 |
| Transesophageal echocardiogram during heart surgery An ultrasound of the heart performed using a probe inserted into the esophagus while surgery on the heart or major blood vessels is taking place, including a written report. |
28 | $177 | $589 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
28 | $101 | $278 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
24 | $135 | $392 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
21 | $20 | $65 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
13 | $20 | $56 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
11 | $17 | $56 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
11 | $11 | $38 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
14.6% high complexity
24.5% medium
60.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,970
Total received (2018-2024)
Avg $996/year across 7 years
Top 34% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
285
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,970 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$657
2023
$2,120
2022
$1,080
2021
$668
2020
$237
2019
$1,573
2018
$635
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$177
Novartis Pharmaceuticals Corporation
$101
Philips North America LLC
$68
Boehringer Ingelheim Pharmaceuticals, Inc.
$52
Lexicon Pharmaceuticals, Inc.
$51
PFIZER INC.
$48
Edwards Lifesciences Corporation
$38
E.R. Squibb & Sons, L.L.C.
$30
HEARTFLOW, INC.
$23
Medtronic, Inc.
$22
Janssen Pharmaceuticals, Inc
$17
United Therapeutics Corporation
$15
AstraZeneca Pharmaceuticals LP
$15
Top 3 companies account for 52.7% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$1,484
Boston Scientific Corporation
$1,335
Janssen Pharmaceuticals, Inc
$565
Novartis Pharmaceuticals Corporation
$495
E.R. Squibb & Sons, L.L.C.
$460
Boehringer Ingelheim Pharmaceuticals, Inc.
$450
SANOFI-AVENTIS U.S. LLC
$350
Amgen Inc.
$261
PFIZER INC.
$175
Medtronic, Inc.
$148
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$143
AstraZeneca Pharmaceuticals LP
$106
Actelion Pharmaceuticals US, Inc.
$85
Impulse Dynamics (USA) Inc.
$82
AngioDynamics, Inc.
$69
Astellas Pharma US Inc
$68
Philips North America LLC
$68
Novo Nordisk Inc
$65
Lexicon Pharmaceuticals, Inc.
$65
Edwards Lifesciences Corporation
$64
Merck Sharp & Dohme LLC
$59
BOSTON SCIENTIFIC CORPORATION
$43
Chiesi USA, Inc.
$39
Regeneron Healthcare Solutions, Inc.
$35
Resmed Corp
$25
ARALEZ PHARMACEUTICALS US INC.
$25
HEARTFLOW, INC.
$23
Cook Medical LLC
$19
Kiniksa Pharmaceuticals, Ltd.
$17
Tactile Systems Technology Inc
$17
Alnylam Pharmaceuticals Inc.
$17
Philips Electronics North America Corporation
$17
Relypsa, Inc.
$15
Amarin Pharma Inc.
$15
United Therapeutics Corporation
$15
SCPHARMACEUTICALS INC.
$14
Otsuka America Pharmaceutical, Inc.
$13
ARBOR PHARMACEUTICALS, INC.
$12
Bayer HealthCare Pharmaceuticals Inc.
$11
Top 3 companies account for 48.6% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · AIR 11 · AVIVO · Adempas · Arcalyst · Axios · BRILINTA · CAMZYOS · CLEVIPREX · CardioMEMS HF System · Corlanor · DUPIXENT · ELIQUIS · EMBLEM · EMBLEM SICD ELECTRODE DELIVERY SYSTEM · ENTRESTO · Edarbyclor · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Ellipse ICD · FARXIGA · FFRct · FUROSCIX · Flexitouch Plus · Fortify Assura · GENERAL TACHY · GENERAL THERAPIES · HeartMate 3 Left Ventricular Dev · Inpefa · JARDIANCE · JETSTREAM SC · KENGREAL · LATITUDE Communicator Power Supply · LEQVIO · LEXISCAN · LINQ II · LUX DX · LUX-DX · LifeVest · MITRACLIP · MULTAQ · Merlin Connectivity and Remote · Mitra Clip system · MitraClip System · ONPATTRO · OPSUMIT · OPTIMIZER · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Pacemakers · REVEAL LINQ · Repatha · Reveal LINQ · Rybelsus · SAMSCA · SAPIEN 3 Ultra RESILIA · TYVASO · VERQUVO · VIGILANT · Varithena Administration Pack · Vascepa · Veltassa · VersaCross Access Solution · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZILVER PTX · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
36
Per 100K population
4.6
County median income
$88,531
Nearest hospital
ST JOSEPH'S MEDICAL CENTER OF STOCKTON
4.2 mi
4.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Basra is a cardiac & electrophysiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Basra experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Basra performed 816 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Basra receive payments from pharmaceutical companies?
Yes. Dr. Basra received a total of $6,970 from 39 companies across 285 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Basra's costs compare to other cardiologists in Stockton?
Dr. Basra's average Medicare payment per service is $79. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Basra) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Stockton
Browse cardiologists in Stockton ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology